Mark Fountain

Title: Mark Fountain: Innovator in Phosphodiester Synthesis

Introduction

Mark Fountain is a notable inventor based in Mantua, NJ (US). He has made significant contributions to the field of chemistry, particularly in the synthesis of phosphodiesters. His innovative approach has led to the development of a unique process that enhances the efficiency of phosphodiester preparation.

Latest Patents

Mark Fountain holds a patent for a process for synthesizing phosphodiesters. This patent describes a method that involves several key steps: the reaction of a first alcohol with phosphorous trichloride to form a phosphorodichlorodite, followed by the reaction of the phosphorodichlorodite with an amine to create a phosphorodiamidite. The process continues with a reaction involving a second alcohol, which may be the same as the first, to form a phosphoramidite diester. Finally, hydrolysis and oxidation of the phosphoramidite yield the desired phosphodiester. The chemical structures involved may include various organic moieties, enhancing the versatility of the synthesis.

Career Highlights

Mark Fountain is currently associated with Epix Medical, Inc., where he applies his expertise in chemical synthesis. His work has been instrumental in advancing the company's research and development efforts. With a focus on innovative solutions, he continues to contribute to the field of medical technology.

Collaborations

Mark has collaborated with several professionals in his field, including John C Amedio, Jr. and Paul J Bernard. These collaborations have fostered a productive environment for innovation and development.

Conclusion

Mark Fountain's contributions to the synthesis of phosphodiesters exemplify the impact of innovative thinking in chemistry. His patent and ongoing work at Epix Medical, Inc. highlight his commitment to advancing scientific knowledge and technology.